Literature DB >> 9738063

Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission.

S Le Pogam1, D Le Chapois, R Christen, F Dubois, F Barin, A Goudeau.   

Abstract

This study reports four cases of transmission of the rare hepatitis C virus genotype 4 which occurred in a hemodialysis unit and originated from a single source of infection. Phylogenetic analyses performed with the NS5b domain showed that all four patients with secondary infections were infected with virus strains very similar to that of the index patient. Cross infections probably resulted from breaches in safety precautions and lack of dialysis machine sterilization.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9738063      PMCID： PMC105107          DOI： 10.1128/JCM.36.10.3040-3043.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Prevention of viral hepatitis in dialysis units: isolation and technical management of dialysis.

Authors:  S Chiaramonte; A Tagger; M L Ribero; A Grossi; M Milan; G La Greca
Journal:  Nephron       Date:  1992       Impact factor: 2.847

2.  Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping.

Authors:  S Le Pogam; F Dubois; R Christen; C Raby; A Cavicchini; A Goudeau
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

3.  There are two major types of hepatitis C virus in Japan.

Authors:  N Enomoto; A Takada; T Nakao; T Date
Journal:  Biochem Biophys Res Commun       Date:  1990-08-16       Impact factor: 3.575

4.  Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.

Authors:  M François; F Dubois; D Brand; Y Bacq; C Guerois; C Mouchet; J Tichet; A Goudeau; F Barin
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

5.  Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment.

Authors:  T Allander; C Medin; S H Jacobson; L Grillner; M A Persson
Journal:  J Med Virol       Date:  1994-08       Impact factor: 2.327

6.  Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group.

Authors:  M Jadoul; C Cornu; C van Ypersele de Strihou
Journal:  Kidney Int       Date:  1993-12       Impact factor: 10.612

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.

Authors:  C Caramelo; S Navas; M L Alberola; T Bermejillo; A Reyero; V Carreño
Journal:  Nephron       Date:  1994       Impact factor: 2.847

9.  Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants.

Authors:  S W Chan; F McOmish; E C Holmes; B Dow; J F Peutherer; E Follett; P L Yap; P Simmonds
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

10.  Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.

Authors:  P Simmonds; E C Holmes; T A Cha; S W Chan; F McOmish; B Irvine; E Beall; P L Yap; J Kolberg; M S Urdea
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891
View more
  17 in total

1.  Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients.

Authors:  Sylvie Corbet; Jens Bukh; Anja Heinsen; Anders Fomsgaard
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Impact of hepatitis B and hepatitis C virus infections in a hematology-oncology unit at a children's hospital in Nicaragua, 1997 to 1999.

Authors:  Kirsten Visoná; Fulgencio Baez; Lizeth Taylor; René Berríos; Bernal León; Carlos Pacheco; Roberto Jirón; Ronald B Luftig; M Mercedes Somarriba
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 3.  Hepatitis C virus screening and management of seroconversions in hemodialysis facilities.

Authors:  Chukwuma Mbaeyi; Nicola D Thompson
Journal:  Semin Dial       Date:  2013-05-31       Impact factor: 3.455

4.  The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies.

Authors:  Mitra Mirzaee; Ramin Yaghobi; Mani Ramzi; Mahdi Roshan Nia
Journal:  Mol Biol Rep       Date:  2011-05-20       Impact factor: 2.316

5.  Hepatitis C virus infection in haemodialysis: the 'no-isolation' policy should not be generalized.

Authors:  Sanjay Kumar Agarwal; Suresh Chand Dash; Sanjay Gupta; Ravinder Mohan Pandey
Journal:  Nephron Clin Pract       Date:  2009-01-16

6.  Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: outbreak investigation and infection outcome.

Authors:  Simone Lanini; Isabella Abbate; Vincenzo Puro; Fabrizio Soscia; Franceso Albertoni; Walter Battisti; Amilacare Ruta; Maria R Capobianchi; Giuseppe Ippolito
Journal:  BMC Infect Dis       Date:  2010-08-27       Impact factor: 3.090

Review 7.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus.

Authors:  Nahed Ismail; Geoffrey E Fish; Michael B Smith
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

9.  Use of the minimum spanning tree model for molecular epidemiological investigation of a nosocomial outbreak of hepatitis C virus infection.

Authors:  Enea Spada; Luciano Sagliocca; John Sourdis; Anna Rosa Garbuglia; Vincenzo Poggi; Carmela De Fusco; Alfonso Mele
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study.

Authors:  Syria Laperche; Françoise Lunel; Jacques Izopet; Sophie Alain; Paul Dény; Gilles Duverlie; Catherine Gaudy; Jean-Michel Pawlotsky; Jean-Christophe Plantier; Bruno Pozzetto; Vincent Thibault; François Tosetti; Jean-Jacques Lefrère
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.